https://www.selleckchem.com/products/CX-3543.html
We also highlight advances in the development and preclinical validation of pharmacological compounds that target β-Klotho and/or the β-Klotho-FGFRs complex for the treatment of T2DM. Given the remarkable advances in this field, we also discuss outstanding research questions and the many challenges in the clinical development of β-Klotho-based therapies. There has been an alarming increase in colorectal cancer (CRC) incidence among young adults aged 50years, and factors driving this upward trend are unknown. This study investigated
Like
Comment
Share
